ID Title Authors Journal Publication Year DOI
178. The toxicity of fluoroacetate and the tricarboxylic acid cycle. 1949. Li?becq, C; Peters, R A Biochimica et Biophysica Acta 1905
145. Rapid purification and characterization of F1-ATPase of Vibrio parahaemolyticus. Sakai, Y; Kanazawa, H; Tsuda, M; Tsuchiya, T Biochimica et Biophysica Acta 1990 10.1016/0005-2728(90)90104-c
152. Inhibition of Escherichia coli H+-ATPase by venturicidin, oligomycin and ossamycin. Perlin, D S; Latchney, L R; Senior, A E Biochimica et Biophysica Acta 1985 10.1016/0005-2728(85)90254-3
144. F0F1-ATPase of Vibrio parahaemolyticus: purification using new detergents and characterization. Ogawa, W; Izawa, S; Sakai-Tomita, Y; Moritani, C; Tsuda, M; Kinomura, K; Kitazawa, S; Tsuchiya, T Biochimica et Biophysica Acta 1994 10.1016/0005-2728(94)90023-x
120. Inhibition of bovine heart mitochondrial and Paracoccus denitrificans NADH----ubiquinone reductase by dequalinium chloride and three structurally related quinolinium compounds. Anderson, W M; Patheja, H S; Delinck, D L; Baldwin, W W; Smiley, S T; Chen, L B Biochemistry international 1989
129. Inhibition of NADH-ubiquinone reductase activity by N,N'-dicyclohexylcarbodiimide and correlation of this inhibition with the occurrence of energy-coupling site 1 in various organisms. Yagi, T Biochemistry 1987 10.1021/bi00384a025
221. Uncoupling of Oxidative Phosphorylation by Carbonyl Cyanide Phenylhydrazones. I. Some Characteristics of m-CI-CCP Action on Mitochondria and Chloroplasts Heytler, P. G. Biochemistry 1963 10.1021/bi00902a031
166. Structural basis for the quinone reduction in the bc1 complex: a comparative analysis of crystal structures of mitochondrial cytochrome bc1 with bound substrate and inhibitors at the Qi site. Gao, Xiugong; Wen, Xiaoling; Esser, Lothar; Quinn, Byron; Yu, Linda; Yu, Chang-An; Xia, Di Biochemistry 2003 10.1021/bi0341814
42. The effect of hexachlorophene on the respiration of brain and liver mitochondria. Cammer, W; Moore, C L Biochemical and Biophysical Research Communications 1972 10.1016/0006-291x(72)90066-6
148. Resistance of thermophilic ATPase (TF1) to specific F1-atpase inhibitors including local anesthetics. Saishu, T; Kagawa, Y; Shimizu, R Biochemical and Biophysical Research Communications 1983 10.1016/0006-291x(83)91691-1
118. Aminoethylcysteine ketimine decarboxylated dimer inhibits mitochondrial respiration by impairing electron transport at complex I level. Pecci, L; Montefoschi, G; Fontana, M; Cavallini, D Biochemical and Biophysical Research Communications 1994 10.1006/bbrc.1994.1293
220. A new class of uncoupling agents--carbonyl cyanide phenylhydrazones. Heytler, P G; Prichard, W W Biochemical and Biophysical Research Communications 1962 10.1016/0006-291X(62)90189-4
99. Complex I and complex III of mitochondria have common inhibitors acting as ubiquinone antagonists. Degli Esposti, M; Ghelli, A; Crimi, M; Estornell, E; Fato, R; Lenaz, G Biochemical and Biophysical Research Communications 1993 10.1006/bbrc.1993.1161
141. Piceatannol, a stilbene phytochemical, inhibits mitochondrial F0F1-ATPase activity by targeting the F1 complex. Zheng, J; Ramirez, V D Biochemical and Biophysical Research Communications 1999 10.1006/bbrc.1999.1063
213. Bioenergetic disruption of human micro-vascular endothelial cells by antipsychotics. Elmorsy, Ekramy; Smith, Paul A Biochemical and Biophysical Research Communications 2015 10.1016/j.bbrc.2015.03.122
307. Impact of pharmacological agents on mitochondrial function: a growing opportunity? Stoker, Megan L; Newport, Emma; Hulit, James C; West, A Phillip; Morten, Karl J Biochemical Society Transactions 2019 10.1042/BST20190280
109. New inhibitors of complex I of the mitochondrial electron transport chain with activity as pesticides. Hollingworth, R M; Ahammadsahib, K I; Gadelhak, G; McLaughlin, J L Biochemical Society Transactions 1994 10.1042/bst0220230
207. Inhibition and uncoupling of oxidative phosphorylation by nonsteroidal anti-inflammatory drugs Moreno-S?nchez, Rafael; Bravo, Concepci?n; V?squez, C?sar; Ayala, Guadalupe; Silveira, Luis H; Mart1nez-Lav1n, Manuel Biochemical Pharmacology 1999 10.1016/S0006-2952(98)00330-X
113. Pethidine analogues, a novel class of potent inhibitors of mitochondrial NADH: ubiquinone reductase. Filser, M; Werner, S Biochemical Pharmacology 1988 10.1016/0006-2952(88)90245-6
237. Tianeptine, a new tricyclic antidepressant metabolized by beta-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice. Fromenty, B; Freneaux, E; Labbe, G; Deschamps, D; Larrey, D; Letteron, P; Pessayre, D Biochemical Pharmacology 1989 10.1016/0006-2952(89)90580-7
240. Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone. Kennedy, J A; Unger, S A; Horowitz, J D Biochemical Pharmacology 1996 10.1016/0006-2952(96)00204-3
122. The antianginal agent ranolazine is a weak inhibitor of the respiratory complex I, but with greater potency in broken or uncoupled than in coupled mitochondria. Wyatt, K M; Skene, C; Veitch, K; Hue, L; McCormack, J G Biochemical Pharmacology 1995 10.1016/0006-2952(95)02042-x
284. Mechanisms of anti-cancer action and pharmacology of clofarabine. Zhenchuk, Anna; Lotfi, Koroush; Juliusson, Gunnar; Albertioni, Freidoun Biochemical Pharmacology 2009 10.1016/j.bcp.2009.06.094
297. Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases. Szabo, Aliz; Sumegi, Katalin; Fekete, Katalin; Hocsak, Eniko; Debreceni, Balazs; Setalo, Gyorgy; Kovacs, Krisztina; Deres, Laszlo; Kengyel, Andras; Kovacs, Dominika; Mandl, Jozsef; Nyitrai, Miklos; Febbraio, Mark A; Gallyas, Ferenc; Sumegi, Balazs Biochemical Pharmacology 2018 10.1016/j.bcp.2018.01.038
33. Thenoyltrifluoroacetone, a potent inhibitor of carboxylesterase activity. Zhang, Jin Gang; Fariss, Marc W Biochemical Pharmacology 2002 10.1016/s0006-2952(01)00871-1
11. Generation of free radicals during the reductive metabolism of nilutamide by lung microsomes: possible role in the development of lung lesions in patients treated with this anti-androgen. Berger, V; Berson, A; Wolf, C; Chachaty, C; Fau, D; Fromenty, B; Pessayre, D Biochemical Pharmacology 1992 10.1016/0006-2952(92)90593-8
283. Mitochondrial Aurora kinase A induces mitophagy by interacting with MAP1LC3 and Prohibitin 2 Bertolin, Giulia; Alves-Guerra, Marie-Clotilde; Burel, Agn?s; Prigent, Claude; Le Borgne, Roland; Tramier, Marc BioRxiv 2020 10.1101/2020.04.06.027896
268. Drug repurposing for mitochondrial diseases using a pharmacological model of complex I deficiency in the yeast Yarrowia lipolytica Perlstein, Ethan Oren BioRxiv 2020 10.1101/2020.01.08.899666
274. Effects of trimetazidine on the calcium transport and oxidative phosphorylation of isolated rat heart mitochondria. Guarnieri, C; Finelli, C; Zini, M; Muscari, C Basic Research in Cardiology 1997 10.1007/BF00805569
299. ROS as a novel indicator to predict anticancer drug efficacy. Zaidieh, Tarek; Smith, James R; Ball, Karen E; An, Qian BMC Cancer 2019 10.1186/s12885-019-6438-y